131 related articles for article (PubMed ID: 2171191)
1. Host species and strain differences affect the ability of an HSV-1 ICP0 deletion mutant to establish latency and spontaneously reactivate in vivo.
Gordon YJ; McKnight JL; Ostrove JM; Romanowski E; Araullo-Cruz T
Virology; 1990 Oct; 178(2):469-77. PubMed ID: 2171191
[TBL] [Abstract][Full Text] [Related]
2. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP; Schaffer PA
J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850
[TBL] [Abstract][Full Text] [Related]
3. Vanadate promotes reactivation and iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals.
Gordon YJ; Romanowski E; Berman J; Vikoren P; Lin LS; Schlessinger D; Araullo-Cruz T
Curr Eye Res; 1990 Oct; 9(10):1015-21. PubMed ID: 2177389
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.
Thompson RL; Sawtell NM
J Virol; 2006 Nov; 80(22):10919-30. PubMed ID: 16943285
[TBL] [Abstract][Full Text] [Related]
5. Herpes Simplex Virus 1 Mutant with Point Mutations in
Mostafa HH; Thompson TW; Konen AJ; Haenchen SD; Hilliard JG; Macdonald SJ; Morrison LA; Davido DJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321311
[TBL] [Abstract][Full Text] [Related]
6. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.
Cai W; Astor TL; Liptak LM; Cho C; Coen DM; Schaffer PA
J Virol; 1993 Dec; 67(12):7501-12. PubMed ID: 8230470
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
8. Herpes Simplex Virus 1 Strains 17
Grams TR; Edwards TG; Bloom DC
J Virol; 2020 Jul; 94(15):. PubMed ID: 32461310
[TBL] [Abstract][Full Text] [Related]
9. Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.
Pan D; Pesola JM; Li G; McCarron S; Coen DM
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847363
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1 strain KOS-63 does not cause acute or recurrent ocular disease and does not reactivate ganglionic latency in vivo.
Stroop WG; Banks MC
Acta Neuropathol; 1994; 87(1):14-22. PubMed ID: 8140892
[TBL] [Abstract][Full Text] [Related]
11. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
12. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.
Leib DA; Coen DM; Bogard CL; Hicks KA; Yager DR; Knipe DM; Tyler KL; Schaffer PA
J Virol; 1989 Feb; 63(2):759-68. PubMed ID: 2536101
[TBL] [Abstract][Full Text] [Related]
13. A thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo.
Stroop WG; Banks MC; Qavi H; Chodosh J; Brown SM
J Med Virol; 1994 Jul; 43(3):297-309. PubMed ID: 7931192
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the cellular E3 ubiquitin ligase SIAH-1 and the viral immediate-early protein ICP0 enables efficient replication of Herpes Simplex Virus type 2 in vivo.
Czechowicz JS; Nagel CH; Voges M; Spohn M; Eibl MM; Hauber J
PLoS One; 2018; 13(8):e0201880. PubMed ID: 30080903
[TBL] [Abstract][Full Text] [Related]
15. The weakly virulent herpes simplex virus type 1 strain KOS-63 establishes peripheral and central nervous system latency following intranasal infection of rabbits, but poorly reactivates in vivo.
Stroop WG; Banks MC
J Neuropathol Exp Neurol; 1992 Sep; 51(5):550-9. PubMed ID: 1325537
[TBL] [Abstract][Full Text] [Related]
16. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency.
Gordon YJ; Araullo-Cruz TP; Romanowski E; Ruziczka L; Balouris C; Oren J; Cheng KP; Kim S
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1230-4. PubMed ID: 3015823
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products.
Zhu XX; Chen JX; Young CS; Silverstein S
J Virol; 1990 Sep; 64(9):4489-98. PubMed ID: 2166826
[TBL] [Abstract][Full Text] [Related]
18. The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.
Loiacono CM; Taus NS; Mitchell WJ
J Neurovirol; 2003 Jun; 9(3):336-45. PubMed ID: 12775417
[TBL] [Abstract][Full Text] [Related]
19. In vivo epinephrine reactivation of ocular herpes simplex virus type 1 in the rabbit is correlated to a 370-base-pair region located between the promoter and the 5' end of the 2.0 kilobase latency-associated transcript.
Hill JM; Maggioncalda JB; Garza HH; Su YH; Fraser NW; Block TM
J Virol; 1996 Oct; 70(10):7270-4. PubMed ID: 8794381
[TBL] [Abstract][Full Text] [Related]
20. HSV-1 shedding by lontophoresis of 6-hydroxydopamine followed by topical epinephrine.
Shimomura Y; Gangarosa LP; Kataoka M; Hill JM
Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1588-94. PubMed ID: 6418684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
